aTyr Pharma, Inc.
ATYR
$0.83
$0.011.55%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 78.69M | 90.20M | 80.35M | 76.35M | 72.13M |
| Total Receivables | 873.00K | 1.04M | 498.00K | 988.00K | 1.74M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 677.00K | 1.77M | 6.65M | 5.93M | 8.09M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 80.24M | 93.01M | 87.49M | 83.27M | 81.95M |
|
|
|||||
| Total Current Assets | 80.24M | 93.01M | 87.49M | 83.27M | 81.95M |
| Net Property, Plant & Equipment | 10.38M | 10.78M | 11.10M | 11.48M | 11.86M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.38M | 2.86M | 2.94M | 2.50M | 3.02M |
| Total Assets | 93.00M | 106.65M | 101.53M | 97.25M | 96.83M |
|
|
|||||
| Total Accounts Payable | 3.89M | 4.06M | 3.88M | 1.53M | 4.32M |
| Total Accrued Expenses | 9.79M | 10.19M | 10.32M | 7.86M | 9.39M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.47M | 1.43M | 1.33M | 1.29M | 1.25M |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 15.15M | 15.68M | 15.53M | 10.68M | 14.97M |
|
|
|||||
| Total Current Liabilities | 15.15M | 15.68M | 15.53M | 10.68M | 14.97M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 10.57M | 10.93M | 11.35M | 11.70M | 12.03M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 25.72M | 26.61M | 26.88M | 22.38M | 27.00M |
|
|
|||||
| Common Stock & APIC | 673.65M | 672.44M | 641.38M | 622.04M | 602.11M |
| Retained Earnings | -606.16M | -592.20M | -566.46M | -546.93M | -532.05M |
| Treasury Stock & Other | -8.00K | -1.00K | -75.00K | -66.00K | -40.00K |
| Total Common Equity | 67.48M | 80.24M | 74.85M | 75.05M | 70.02M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 67.48M | 80.24M | 74.85M | 75.05M | 70.02M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -192.00K | -191.00K | -189.00K | -188.00K | -187.00K |
| Total Equity | 67.29M | 80.04M | 74.66M | 74.86M | 69.83M |
|
|
|||||